Published: March 10, 2010
Healthcare Executives to Discuss Latest Legal, Regulatory and Public Policy Developments at 19th Annual King & Spalding Health Law and Policy Forum

Top healthcare executives and leading legal and policy experts will gather on March 15 to discuss topics ranging from emerging risks in clinical research and government efforts to combat healthcare fraud to the latest prognosis for national health reform at the 19th Annual King & Spalding Health Law and Policy Forum.
The Forum will take place from 8:15 a.m. to 5:00 p.m. EST at the Four Seasons Hotel in Atlanta, Georgia.
Moderated by Richard L. Shackelford, president-elect of the American Health Lawyers Association and a partner at King & Spalding, the program will feature experts from King & Spalding as well as the New America Foundation, Deloitte, KPMG, Coppersmith Schermer & Brockelman and Ethos Partners.
U.S. Senator Johnny Isakson (R-Georgia) will be the keynote speaker. Sen. Isakson will discuss the status of the healthcare debate in Washington and provide an update on other legislative issues facing Congress this year.
Additional forum topics and speakers will include:
-- Medicare Physician Supervision: Requirements for Hospital Outpatient
Services
An assessment of CMS's requirements for physician supervision for all
hospital outpatient services, including the special rules for cardiac
and pulmonary rehabilitation, open issues under the new rules, and how
hospitals can address certain commonly arising situations.
Dennis M. Barry, Partner, King & Spalding; member of the board of
directors of the American Health Lawyers Association
-- Hospital System Employment of Physicians: Where Regulation Meets
Valuation
Insights into the key considerations that impact hospital system
employment of physicians, focusing on compensation valuation issues and
compliant employment structures.
Kevin S. Wilson, Principal, Ethos Partners Healthcare Management Group
Robert M. Keenan III, Partner, King & Spalding
-- Care Coordination Models and EHR: Opportunities and Challenges
A look at innovative care coordination models and payment strategies of
rising interest in the market, the role of electronic health records in
implementing care coordination, financial incentives to pursue these
models, and potential regulatory challenges under current law.
Joseph E. Lynch, Partner, King & Spalding
Kim H. Roeder, Partner, King & Spalding
-- Restrictive Covenants in Healthcare Employment Agreements: Are They
Worth the Pain?
An assessment of the risks and rewards related to including covenants
prohibiting post-employment competition in employment agreements,
solicitation of clients and employees, and disclosure of confidential
information and trade secrets, as well as the approaches taken by states
to enforce (or not) such covenants and changes likely to occur in the
near future.
Michael W. Johnston, Partner, King & Spalding
-- Healthcare Reform: What Now?
A candid discussion of the current state of national healthcare reform
and what the future holds.
Julie Barnes, Deputy Director, Healthcare Policy Program, New America
Foundation
John T. Bigalke, Vice Chairman and U.S. National Industry Leader for
Health Sciences and Government, Deloitte LLP
Beth Schermer, Partner, Coppersmith Schermer & Brockelman PLC
Glen A. Reed, Partner and Chair, Healthcare Industry Practice Group,
King & Spalding; past president of the American Health Lawyers
Association
-- The Evolving Landscape of Government Audits and Investigations: Are You
Prepared for Contractor Combat?
A look at the growing number of government audits and other inquiries
led by a new cadre of government contractors, including Recovery Audit
Contractors (RACs), Medicare Administrative Contractors (MACs), Medicaid
Integrity Contractors (MICs), Program Safeguard Contractors (PSCs) and
Zone Program Integrity Contractors (ZPICs) and related strategies.
Glennon E. Moyers, Partner, Investigative and Integrity Advisory
Services, KPMG LLP
Sara Kay Wheeler, Partner, King & Spalding; member of the board of
directors of the Health Care Compliance Association
-- Clinical Research: Major Developments and Emerging Risks
An analysis of changes in federal policy and scrutiny regarding IRBs,
including the related responsibilities of sponsors and investigators,
the management of conflicts-of-interest in the conduct of clinical
research, and expanded access to investigational products, as well as
trends in federal enforcement related to clinical investigations and
approaches to identifying and mitigating risks.
Beverly H. Lorell, MD, Senior Medical and Policy Advisor, King &
Spalding
Mark S. Brown, Partner, King & Spalding
-- Combating Healthcare Fraud, Abuse and Waste: The Continued Evolution of
the FCA, Compliance Programs, Self-Disclosure and Enforcement
Initiatives
An overview of the current enforcement environment, including important
developments from amendments to the False Claims Act and recent court
decisions, including practical guidance and strategies for difficult
self-disclosure issues and other critical topics for effective
compliance programs.
Ann M. Cook, Partner, King & Spalding
Gary W. Eiland, Partner, King & Spalding; past president of the American
Health Lawyers Association
Richard L. Shackelford, Partner, King & Spalding; president-elect of the
American Health Lawyers Association
The 19th Annual King & Spalding Health Law and Policy Forum is presented with the assistance of:
Forum partner: FTI
Forum co-partners: Ernst & Young; Ethos Partners; and Navigant Consulting
Sponsors: Deloitte; Dixon Hughes; Huron Consulting Group; KPMG; and Sullivan Cotter and Associates
Educational partners: Georgia Association of Healthcare Executives; Georgia Institute on Aging; and Healthcare Financial Management Association (Georgia and Tennessee Chapters)
For additional information on the event and to register, go to: www.kslaw.com/healthcareforum
About King & Spalding
Celebrating 125 years of service, King & Spalding is an international law firm with more than 800 lawyers in Abu Dhabi, Atlanta, Austin, Charlotte, Dubai, Frankfurt, Houston, London, New York, Paris, Riyadh (affiliated office), San Francisco, Silicon Valley and Washington, D.C. The firm represents half of the Fortune 100 and, according to a Corporate Counsel survey in August 2009, ranks fifth in its total number of representations of those companies. For additional information, visit www.kslaw.com.
Copyright © 2012, MarketWire
Copyright © 2012, NewsBlaze,
Daily News